Related Experiment Video
Updated: Mar 21, 2026

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis
A Ghoochani1, M A Schwarz1, E Yakubov1
1Department of Neurosurgery, Universitätsklinikum Erlangen, Medical Faculty of the Friedrich Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.
Abstract:
Microglial cells in the brain tumor microenvironment are associated with enhanced glioma malignancy. They persist in an immunosuppressive M2 state at the peritumoral site and promote the growth of gliomas. Here, we investigated the underlying factors contributing to the abolished immune surveillance. We show that brain tumors escape pro-inflammatory M1 conversion of microglia via CD74 activation through the secretion of the cytokine macrophage migration inhibitory factor (MIF), which results in a M2 shift of microglial cells. Interruption of this glioma-microglial interaction through an antibody-neutralizing approach or small interfering RNA (siRNA)-mediated inhibition prolongs survival time in glioma-implanted mice by reinstating the microglial pro-inflammatory M1 function. We show that MIF-CD74 signaling inhibits interferon (IFN)-γ secretion in microglia through phosphorylation of microglial ERK1/2 (extracellular signal-regulated protein kinases 1 and 2). The inhibition of MIF signaling or its receptor CD74 promotes IFN-γ release and amplifies tumor death either through pharmacological inhibition or through siRNA-mediated knockdown. The reinstated IFN-γ secretion leads both to direct inhibition of glioma growth as well as inducing a M2 to M1 shift in glioma-associated microglia. Our data reveal that interference with the MIF signaling pathway represents a viable therapeutic option for the restoration of IFN-γ-driven immune surveillance.
Insights
Brain tumors hijack microglia, promoting glioma growth by blocking immune surveillance. Inhibiting MIF-CD74 signaling restores microglial M1 function and interferon-gamma, enhancing anti-tumor immunity and survival.
Area of Science:
- Neuro-oncology
- Immunology
- Cell Biology
Background:
- Microglia within the brain tumor microenvironment exacerbate glioma malignancy.
- Microglia adopt an immunosuppressive M2 phenotype, fostering glioma progression and evading immune surveillance.
Purpose of the Study:
- To investigate mechanisms by which gliomas abolish immune surveillance.
- To identify therapeutic targets for restoring anti-tumor immune responses in the glioma microenvironment.
Main Methods:
- Investigated the role of macrophage migration inhibitory factor (MIF) and CD74 signaling in microglia polarization.
- Utilized antibody neutralization and small interfering RNA (siRNA) to inhibit MIF-CD74 interactions.
- Assessed changes in microglial M1/M2 states, interferon-gamma (IFN-γ) secretion, and ERK1/2 phosphorylation.
- Evaluated therapeutic efficacy in glioma-implanted mouse models.
Main Results:
- Glioma cells secrete MIF, activating microglial CD74 and inducing an immunosuppressive M2 shift, thereby inhibiting pro-inflammatory M1 conversion.
- Inhibition of MIF-CD74 signaling reinstated microglial M1 function and IFN-γ secretion.
- IFN-γ release directly inhibited glioma growth and promoted a M2 to M1 shift in microglia.
- Interfering with MIF-CD74 signaling prolonged survival in glioma-bearing mice.
Conclusions:
- The MIF-CD74 pathway is crucial for glioma-induced immune suppression by microglia.
- Targeting MIF-CD74 signaling offers a therapeutic strategy to restore IFN-γ-mediated anti-tumor immunity.
- Restoring microglial pro-inflammatory function is a viable approach for glioma treatment.
More Related Videos
13:28Three-dimensional Confocal Analysis of Microglia/macrophage Markers of Polarization in Experimental Brain Injury
Published on: September 4, 2013
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...